Respiratory specimen transport media — evolved dramatically during COVID-19 from niche molecular transport into mainstream mass-market products — continues evolving post-pandemic as respiratory viral testing with multiplex molecular panels expands beyond COVID-19 to comprehensive respiratory pathogen syndromic testing, with the Transport Media Market reflecting post-pandemic...